3606 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

chairperson. The Committee will also 

allow a 15-minute unscheduled open 

public session for any attendee to 

address issues specific to the topics 

under consideration. At the conclusion 

of the day, the members will vote and 

the Committee will make its 

recommendation(s) to CMS. 

III. Registration Instructions 

CMS’ Coverage and Analysis Group is 

coordinating meeting registration. While 

there is no registration fee, individuals 

must register to attend. You may register 

online at http://www.cms.gov/apps/

events/upcomingevents.asp?

strOrderBy=1&type=3 or by phone by 

contacting the person listed in the FOR

FURTHER INFORMATION CONTACT section of 

this notice by the deadline listed in the 

DATES section of this notice. Please 

provide your full name (as it appears on 

your state-issued driver’s license), 

address, organization, telephone 

number(s), fax number, and email 

address. You will receive a registration 

confirmation with instructions for your 

arrival at the CMS complex or you will 

be notified that the seating capacity has 

been reached. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a federal 

government building; therefore, federal 

security measures are applicable. We 

recommend that confirmed registrants 

arrive reasonably early, but no earlier 

than 45 minutes prior to the start of the 

meeting, to allow additional time to 

clear security. Security measures 

include the following: 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means, of all persons 

entering the building. We note that all 

items brought into CMS, whether 

personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not 

registered in advance will not be 

permitted to enter the building and will 

be unable to attend the meeting. The 

public may not enter the building earlier 

than 45 minutes prior to the convening 

of the meeting. All visitors must be 

escorted in areas other than the lower 

and first floor levels in the Central 

Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

Dated: January 9, 2015. 

Patrick Conway, 

Deputy Administrator for Innovation and 

Quality and CMS Chief Medical Officer. 

Centers for Medicare & Medicaid Services. 

[FR Doc. 2015–00935 Filed 1–22–15; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

OMB No.: 0970–0401. 

Description: Executive Order 12862 

directs Federal agencies to provide 

service to the public that matches or 

exceeds the best service available in the 

private sector. In order to work 

continuously to ensure that the 

Administration for Children and 

Families’ programs are effective and 

meet our customers’ needs we use a 

generic clearance process to collect 

qualitative feedback on our service 

delivery. This collection of information 

is necessary to enable ACF to garner 

customer and stakeholder feedback in 

an efficient timely manner, in accord 

with our commitment to improving 

service delivery. The information 

collected from our customers and 

stakeholders will help ensure that users 

have an effective, efficient and 

satisfying experience with the programs. 

This feedback will provide insights into 

customer or stakeholder perceptions, 

experiences and expectations, provide 

an early warning of issues with service, 

or focus attention on areas where 

communication, training or change in 

operation might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between 

ACF and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

This request is an extension of the 

‘‘generic fast-track’’ process offered to 

all government agencies by OMB in 

2010. Fast-track means each request 

receives approval five days after 

submission, if no issues are brought to 

ACF’s attention by OMB within the five 

days. 

Respondents: Individuals, State and 

Local Governments, and Tribes. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Survey .............................................................................................................. 3000 1 0.5 2500 

Estimated Total Annual Burden 

Hours: 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Planning, Research and Evaluation, 370 

L’Enfant Promenade SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. Email address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Email: OIRA_

SUBMISSION@OMB.EOP.GOV, Attn: 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3607 

Desk Officer for the Administration for 

Children and Families. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2015–01122 Filed 1–22–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Number 93.645] 

Correction to the Notice of Allotment 

Percentages to States for Child 

Welfare Services State Grants 

AGENCY: Administration on Children, 

Youth and Families, Administration for 

Children and Families, Department of 

Health and Human Services. 

ACTION: Notice; correction. 

SUMMARY: The Administration on 

Children, Youth and Families, 

Administration on Children and 

Families published a document in the 

Federal Register of November 28, 2014, 

concerning the biennial publication of 

allotment percentages for States under 

Title IV–B subpart 1, Child Welfare 

Services State Grants Program. The 

document contained an incorrect 

allotment percentage for the District of 

Columbia. 

FOR FURTHER INFORMATION CONTACT: 

Deborah Bell, Grants Fiscal Management 

Specialist, Office of Grants 

Management, Office of Administration, 

Administration for Children and 

Families, telephone (202) 401–4611. 

Correction: In the Federal Register of 

November 28, 2014, in FR. Doc. 2014– 

28135, on page 70873, in the second 

column, correct the ‘‘Allotment 

Percentage’’ for the District of Columbia 

from ‘‘14.17’’ to ‘‘30.00.’’ 

Melody Wayland, 

Senior Grants Policy Specialist, Office of 

Administration. 

[FR Doc. 2015–01106 Filed 1–22–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0312] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Extralabel Drug 

Use in Animals 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by February 

23, 2015. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0325. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Road; COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Extralabel Drug Use in Animals—21 

CFR 530 (OMB Control Number—0910– 

0325)—(Extension) 

The Animal Medicinal Drug Use 

Clarification Act of 1994 allows a 

veterinarian to prescribe the extralabel 

use of approved new animal drugs. 

Also, it permits FDA, if it finds that 

there is a reasonable probability that the 

extralabel use of an animal drug may 

present a risk to the public health, to 

establish a safe level for a residue from 

the extralabel use of the drug, and to 

require the development of an analytical 

method for the detection of residues 

above that established safe level. 

Although to date we have not 

established a safe level for a residue 

from the extralabel use of any new 

animal drug and, therefore, have not 

required the development of analytical 

methodology, we believe that there may 

be instances when analytical 

methodology will be required. We are, 

therefore, estimating the reporting 

burden based on two methods being 

required annually. The requirement to 

establish an analytical method may be 

fulfilled by any interested person. We 

believe that the sponsor of the drug will 

be willing to develop the method in 

most cases. Alternatively, FDA, the 

sponsor, and perhaps a third party may 

cooperatively arrange for method 

development. The respondents may be 

sponsors of new animal drugs, State, or 

Federal and/or State Agencies, 

academia, or individuals. 

In the Federal Register of November 

4, 2014 (79 FR 65408), FDA published 

a 60-day notice requesting public 

comment on the proposed collection of 

information. No comments were 

received. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

21 CFR Section Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

530.22(b) .............................................................................. 2 1 2 4,160 8,320 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 


tkelley on DSK3SPTVN1PROD with NOTICES